Optimizing Outcomes in Patients with HER2+ Metastatic Breast Cancer: Translating Evidence to Clinical Practice

home / around-the-practice / optimizing-outcomes-in-patients-with-her2-metastatic-breast-cancer-translating-evidence-to-clini

Drs. Sara Hurvitz, Stefania Maraka, and Ruta Rao discuss the evolving landscape of metastatic HER2+ breast cancer, highlighting recent clinical trials and the management of patients with brain metastases.